RE: winners and losers in JPM 201912 Jan 2019 09:31
Snippet from India pharma report.....
"New legislation announced in recent days will remove price restrictions on novel therapies developed by foreign companies, for the first five years at least, including drugs for treating orphan diseases.
These price caps were introduced under the Drug Price Control Order (DPCO) of 2013, which has been blamed by the industry for a decline in R&D, and fewer new drug introductions in India".